![](/img/cover-not-exists.png)
Week 96 analysis of rilpivirine or efavirenz in HIV-1-infected patients with baseline viral load ≤ 100 000 copies/mL in the pooled ECHO and THRIVE phase 3, randomized, double-blind trials
Molina, J-M, Clumeck, N, Orkin, C, Rimsky, LT, Vanveggel, S, Stevens, MVolume:
15
Language:
english
Journal:
HIV Medicine
DOI:
10.1111/hiv.12071
Date:
January, 2014
File:
PDF, 158 KB
english, 2014